VISEN Pharmaceuticals (HKG:2561)
Hong Kong
· Delayed Price · Currency is HKD
45.70
+0.20 (0.44%)
May 30, 2025, 11:54 AM HKT
VISEN Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -170.72 | -249.57 | -288.97 |
| Depreciation & Amortization | 4.4 | 6.15 | 6.67 |
| Other Amortization | 0.71 | 0.85 | 0.72 |
| Loss (Gain) From Sale of Assets | - | 0.24 | 0.09 |
| Stock-Based Compensation | 31.73 | -12.27 | 93.51 |
| Other Operating Activities | -38.7 | 67.12 | -0.77 |
| Change in Accounts Payable | 1.36 | -12.08 | 4.44 |
| Change in Other Net Operating Assets | -43.85 | -71.75 | -62.25 |
| Operating Cash Flow | -217.98 | -271.31 | -246.55 |
| Capital Expenditures | -0.29 | -0.52 | -1.48 |
| Sale (Purchase) of Intangibles | - | - | -0.28 |
| Investing Cash Flow | -0.29 | -0.52 | -1.77 |
| Long-Term Debt Repaid | - | -4.95 | -5.78 |
| Net Debt Issued (Repaid) | -3.46 | -4.95 | -5.78 |
| Other Financing Activities | -1.1 | -2.01 | -2.17 |
| Financing Cash Flow | -4.56 | -6.95 | -7.95 |
| Foreign Exchange Rate Adjustments | -0.08 | 0.11 | 0.07 |
| Net Cash Flow | -222.91 | -278.68 | -256.2 |
| Free Cash Flow | -218.27 | -271.83 | -248.03 |
| Free Cash Flow Per Share | -23.37 | -29.10 | - |
| Levered Free Cash Flow | - | -67.66 | - |
| Unlevered Free Cash Flow | - | -67.46 | - |
| Change in Net Working Capital | - | -25.39 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.